ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
cas33VFL
|
663 |
241K |
2 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
663
|
241K
|
2
|
|
ASX - By Stock
|
LIS |
Re:
Why they trying to keep shareprice low
|
|
cas33VFL
|
15 |
4.4K |
3 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
15
|
4.4K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
cas33VFL
|
11K |
4.0M |
5 |
06/08/24 |
06/08/24 |
General
|
11K
|
4.0M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
22K
|
7.8M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
cas33VFL
|
391 |
82K |
12 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
82K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
cas33VFL
|
391 |
82K |
8 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
82K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
cas33VFL
|
146 |
44K |
23 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
146
|
44K
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
3 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
22K
|
7.8M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
cas33VFL
|
2.2K |
774K |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
2.2K
|
774K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
9 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
1.0K
|
308K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
cas33VFL
|
58 |
17K |
16 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
58
|
17K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
cas33VFL
|
234 |
65K |
20 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
234
|
65K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
cas33VFL
|
250 |
67K |
4 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
67K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
cas33VFL
|
37 |
12K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
37
|
12K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
cas33VFL
|
37 |
12K |
4 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
37
|
12K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
cas33VFL
|
11K |
4.0M |
4 |
23/04/24 |
23/04/24 |
General
|
11K
|
4.0M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification of cessation of securities - RAC
|
|
cas33VFL
|
64 |
20K |
3 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
64
|
20K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
cas33VFL
|
89 |
36K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
89
|
36K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
cas33VFL
|
89 |
36K |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
89
|
36K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
17 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
10 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
11 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
11 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
32 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
32
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
13 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
13
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
19 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
cas33VFL
|
905 |
272K |
34 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
905
|
272K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
1.0K
|
308K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
1.0K
|
308K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
1.0K
|
308K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to Present at Euroz Hartley Institutional Conference
|
|
cas33VFL
|
37 |
10K |
14 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
37
|
10K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to Present at Euroz Hartley Institutional Conference
|
|
cas33VFL
|
37 |
10K |
6 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
37
|
10K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
9 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
8 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
22K
|
7.8M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
9 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
1.0K
|
308K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
cas33VFL
|
89 |
36K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
89
|
36K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
cas33VFL
|
89 |
36K |
26 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
89
|
36K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
cas33VFL
|
89 |
36K |
10 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
89
|
36K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
18 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
1.0K
|
308K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
cas33VFL
|
2.2K |
774K |
47 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
2.2K
|
774K
|
47
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
cas33VFL
|
11K |
4.0M |
19 |
25/02/24 |
25/02/24 |
General
|
11K
|
4.0M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
cas33VFL
|
1.0K |
308K |
5 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
1.0K
|
308K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
cas33VFL
|
54 |
14K |
2 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
54
|
14K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
cas33VFL
|
54 |
14K |
13 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
54
|
14K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Initial COBRA results
|
|
cas33VFL
|
51 |
15K |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
51
|
15K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
cas33VFL
|
2.3K |
784K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
2.3K
|
784K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
cas33VFL
|
22K |
7.8M |
2 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
22K
|
7.8M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
cas33VFL
|
2.3K |
784K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
2.3K
|
784K
|
3
|
|